Simvastatin attenuates chromium-induced nephrotoxicity in rats

Area of Science:

• Environmental Toxicology
• Pharmacology
• Nephrology

Background:

• Hexavalent Chromium (Cr (VI)) is a toxic environmental agent causing kidney damage via oxidative stress.
• Understanding protective mechanisms against Cr (VI) toxicity is crucial due to its widespread presence.

Purpose of the Study:

• To investigate the protective potential of simvastatin (SIMV) against Cr (VI)-induced nephrotoxicity in a rat model.
• To evaluate the impact of SIMV on biochemical markers and kidney tissue morphology following chromium exposure.

Main Methods:

• Adult male Wistar rats were exposed to varying doses of sodium dichromate (Cr (VI)) with or without simvastatin (SIMV) pretreatment.
• Kidney tissues were analyzed for malondialdehyde (MDA) and glutathione (GSH) levels, alongside histopathological examinations.
• Animals were divided into eight groups, receiving SIMV, vehicle, Cr (VI) alone, or SIMV followed by Cr (VI).

Main Results:

• Cr (VI) exposure led to a dose-dependent increase in MDA and a decrease in GSH, indicating oxidative stress and kidney damage.
• Histopathological analysis revealed significant microscopic damage in Cr (VI)-treated rat kidneys.
• Simvastatin treatment reversed the biochemical alterations (reduced MDA, increased GSH) and ameliorated the observed kidney damage.

Conclusions:

• Simvastatin demonstrates a protective effect against Hexavalent Chromium-induced nephrotoxicity in rats.
• SIMV mitigates Cr (VI)-induced kidney injury by counteracting oxidative stress and restoring normal kidney tissue morphology.